.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Lobo is stocked at 62 licensed dispensaries across New York, New Jersey, and Illinois, 49 of them in New York, with the deepest coverage in New York, Queens, Brooklyn, Staten Island, and Rochester. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, Lobo’s mix concentrated into Flower at 49.02% share and Pre-Roll at 34.71%, while Concentrates expanded to 16.27% share; the YoY split shows Flower down 29.27% and Pre-Roll down 51.06%, contrasted with Concentrates up 119.53%. Month over month, Flower declined 20.93% and Pre-Roll fell 25.15%, while Concentrates grew 6.07%, and the category anchor rank in Flower sat at position 76 in New York. The pattern implies Lobo is losing volume in its historic Flower and Pre-Roll bases while backfilling with higher-growth Concentrates, shifting reliance toward a smaller but expanding niche.
The combination of a 13.27% YoY price decrease and a 32.28% YoY sales decline suggests a volume and mix headwind concentrated in Flower and Pre-Roll, even as Concentrates’ 119.53% YoY growth and 6.07% MoM uptick reallocate share toward higher-intensity segments. With Flower MoM at -20.93% and Pre-Roll MoM at -25.15%, the short-term trajectory remains contractionary in the two largest bases, while a 16.27% share for Concentrates creates a growing counterweight. The implication is that Lobo’s near-term positioning is migrating from mainstream inhalables toward a potency-led Concentrates identity, which could reduce exposure to rank pressure in Flower (rank 76) but increases sensitivity to a narrower consumer set.
Competitive Landscape
Lobo sits at #76 in New York Flower in August 2026, down 15 places year over year from #61 and slipping 2 spots since May 2026 from #74, while its historical peak of #47 in October 2025 marks a 29-rank decline from that high; by contrast, Find. climbed from #6 to #1 with 30.27% YoY sales growth and Grassroots rose from #14 to #4 alongside an 88.43% YoY increase, indicating that Lobo’s downward rank trajectory amid competitors’ upward moves points to share erosion and a need to reposition against faster-growing leaders.
Notable Products
Bold - Blue Dream Infused Pre-Roll (1g) posted the steepest movement with a -49.2% month-over-month change and sat at rank 5, while Tangie Cream (3.5g) fell -27.6% at rank 8, indicating concentrated pressure on infused and value Flower. Blueberry Diesel Infused Flower (3.5g) slipped -6.9% yet held rank 2, and Pineapple Express Pre-Roll 5-Pack (2.5g) declined -25.6% at rank 6, pointing to softness in multi-pack Pre-Roll even as Pineapple Express Blunt (1g) was rank 1. Four of the top ten are Pre-Roll SKUs and three are Flower SKUs, with Pre-Roll spans from rank 1 to rank 9 and Flower anchored at ranks 2 and 8, implying a pivot toward single-stick premium positioning over bulk or infused formats in August 2026.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
